Impress employers and recruiters.
Choose from hundreds of resume examples.
Impress employers and recruiters.
Choose from hundreds of resume examples.
Tailor your resume to this Associate Director, Strategic Accounts (New York) role.
Rezi rewrites your resume against ADC Therapeutics America Inc's job description. Free.
Tailor your resume to this Associate Director, Strategic Accounts (New York) role.
Rezi rewrites your resume against ADC Therapeutics America Inc's job description. Free.
Don't guess if your resume is good enough.
See how it scores against the Associate Director, Strategic Accounts (New York) posting at ADC Therapeutics America Inc — free, in seconds.
Don't guess if your resume is good enough.
See how it scores against the Associate Director, Strategic Accounts (New York) posting at ADC Therapeutics America Inc — free, in seconds.
About the Role
We are seeking a passionate and driven hematology account manager to join ADCT’s Field Sales team, calling on the major academic institutions in New York City and New Jersey. The Associate Director of Strategic Accounts (ADSA) will report to the Sr Area Business Director and will lead a team of 2 Hematology Therapeutic Specialists (HTS) who are primarily focused on community pull-through.
Responsibilities
- Meet or exceed business objectives within our compliance framework
- Establish partnership with key stakeholders within accounts and serve as the single-point of contact within the account for ADC Therapeutics
- Full people management responsibilities for their team of Hematology Therapeutic Specialists
- Develop an understanding of accounts and perception/sentiment towards ZYNLONTA
- Develop robust account plans for each key account and collaborate across the organization to execute on plans
- Serve as a player/coach for area business including performance of their own accounts as well as managing the performance of their Hematology Therapeutic Specialists
- Be an expert on the clinical profile of ZYNLONYA and clearly articulate the value proposition to key stakeholders
- Utilize approved materials and resources to drive awareness and advocacy for ZYNLONTA
- Understand mapping of physicians and key stakeholders within each account to best drive advocacy for ZYNLONTA
- Partner with appropriate stakeholders within accounts to ensure a positive experience with ZYNLONTA including office staff, pharmacists, business managers, etc., and triaging requests compliantly
- Participate in account reviews and business reviews with the cross-functional ADCT team
Requirements
- Bachelor’s degree from an accredited college or university
- 7+ years in the Pharmaceutical/Biotech/Medical Device industry preferred
- Oncology/Hematology experience is preferred
- Experience with buy and bill products is preferred
- Account management experience
- People management experience preferred – but not required
- Outstanding communication, listening skills, collaboration, business acumen, follow-through, and ability to influence
- Ability to be flexible and adapt to a changing and complex environment
- Proficiency in MS Word, Excel, PowerPoint and Outlook
- Valid driver’s license and acceptable driving record
- Ability to comply with credentialing
- Travel expectation: On average in your territory 4 days/week and as needed for conference coverage
- Must be able to travel as necessary which may include weekend travel for congresses
Skills
- Communication
- Listening
- Collaboration
- Business acumen
- Follow-through
- Ability to influence
- MS Word
- MS Excel
- MS PowerPoint
- MS Outlook
Location
- New York City
- New Jersey
Work Type
- Field Sales
- Travel
Experience Level
- 7+ years in the Pharmaceutical/Biotech/Medical Device industry
- People management experience preferred
Education Level
- Bachelor’s degree
About the Company
- ADC Therapeutics (NYSE): is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs) with specialized capabilities from clinical through commercialization.
- Our CD-19-directed ADC for relapsed/refractory non-Hodgkin lymphoma, ZYNLONTA® (loncastuxamab tesirine lpyl) has received accelerated approval in the United States and conditional approval from the European Commission.
- ZYNLONTA is also being evaluated in combination with other agents and in earlier lines of DLBCL therapy as well as in indolent lymphomas including follicular lymphoma and marginal zone lymphoma with the potential to reach significantly more patients through expanded use.
- We are a team of approximately 150 patient-focused, purpose-driven employees with a shared mission to transform the treatment paradigm for patients.
- If you’re interested in making a difference in the lives of patients worldwide with a team of like-minded colleagues, operating in a flexible work environment, come join us on our journey!
Equal Opportunity
- ADC Therapeutics is an equal opportunity employer (EEO).
- We are committed to building diverse teams and fostering an inclusive, professional, and respectful work environment where employees are empowered for success.
- We consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.